4.10 References
| 4.1 Gillespie et al (2010) | Gillespie W et al (2010) ‘Hip protectors for preventing hip fractures in older people’ Cochrane Database Systemic Review; 3 |
| 4.1 Dimai & Chandran, (2011) | Dimai HP & Chandran M (2011) ‘Official Positions for FRAX® Clinical Regarding Smoking’ Journal of Clinical Densitometry; 14:190–193 |
| 4.2 Luthra et al (2018) | Luthra et al (2018). Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson’s disease. J Clin Mov Disord 5, 7 |
| 4.7 Torre et al (2019) | Torre et al (2019) Low persistence with oral bisphosphonate treatment in postmenopausal osteoporosis Acta Reumatol Port; 44:114-125 |
| 4.7 Straka et al (2018) | Straka et al (2018). Clinical aspects of adherence to pharmacotherapy in Parkinson disease: a PRISMA-compliant systematic review. Medicine, 97(23). |
Back to previous pagePrevious
4.9 Useful links